L19IL2/L19TNF
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for L19IL2/L19TNF, covering 2015-05-27 to 2024-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients [Phase 2]